Huons Co. Ltd Cash Flow Conversion Efficiency
Huons Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Huons Co. Ltd (243070) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.92 Billion ≈ $7.40 Million USD) by net assets (₩395.25 Billion ≈ $267.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Huons Co. Ltd (2016–2024)
Cash flow conversion efficiency of Huons Co. Ltd from 2016 to 2024. This chart illustrates how Huons Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 243070 stock price and chart for real-time trading data and today's change.
Huons Co. Ltd Cash Flow Conversion Ratio Explained
Huons Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Huons Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Huons Co. Ltd ranked by their cash flow conversion efficiency. Also see market value of Huons Co. Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class B
IS:KRDMB
|
0.031x |
|
Tai-Saw Technology Co Ltd
TWO:3221
|
0.026x |
|
HAPPY BELLY FOOD GRO.INC.
F:W3J
|
N/A |
|
Pine Cliff Energy Ltd
TO:PNE
|
0.107x |
|
Banco Alfa de Investimento S.A
SA:BRIV3
|
-1.114x |
|
Chenghe Acquisition III Co. Class A Ordinary Share
NASDAQ:CHEC
|
-0.002x |
|
Guardian Capital Group Limited
TO:GCG
|
0.049x |
|
Donegal Group B Inc
NASDAQ:DGICB
|
0.016x |
Annual Cash Flow Conversion Efficiency for Huons Co. Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Huons Co. Ltd from 2016 to 2024. Review Huons Co. Ltd (243070) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩345.97 Billion ≈ $234.46 Million |
₩52.56 Billion ≈ $35.62 Million |
0.152x | -3.74% |
| 2023-12-31 | ₩330.41 Billion ≈ $223.92 Million |
₩52.14 Billion ≈ $35.34 Million |
0.158x | +39.22% |
| 2022-12-31 | ₩282.46 Billion ≈ $191.42 Million |
₩32.02 Billion ≈ $21.70 Million |
0.113x | -45.74% |
| 2021-12-31 | ₩266.09 Billion ≈ $180.33 Million |
₩55.59 Billion ≈ $37.67 Million |
0.209x | +7.28% |
| 2020-12-31 | ₩238.80 Billion ≈ $161.83 Million |
₩46.51 Billion ≈ $31.52 Million |
0.195x | -10.06% |
| 2019-12-31 | ₩194.52 Billion ≈ $131.82 Million |
₩42.12 Billion ≈ $28.54 Million |
0.217x | +69.29% |
| 2018-12-31 | ₩163.27 Billion ≈ $110.64 Million |
₩20.88 Billion ≈ $14.15 Million |
0.128x | -48.05% |
| 2017-12-31 | ₩122.69 Billion ≈ $83.15 Million |
₩30.21 Billion ≈ $20.47 Million |
0.246x | -46.72% |
| 2016-12-31 | ₩93.88 Billion ≈ $63.62 Million |
₩43.38 Billion ≈ $29.40 Million |
0.462x | -- |
About Huons Co. Ltd
Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other ch… Read more